Skip to main content
Top
Published in: Current Diabetes Reports 5/2015

01-05-2015 | Hospital Management of Diabetes (GE Umpierrez, Section Editor)

Non-ICU Hospital Care of Diabetes Mellitus in the Elderly Population

Authors: Janice L. Gilden, Aditi Gupta

Published in: Current Diabetes Reports | Issue 5/2015

Login to get access

Abstract

The concept of lower is better when considering the goal for glycemic control in patients with diabetes mellitus has recently been challenged due to recent studies, such as ACCORD, ADVANCE, and VADT, which have observed increased morbidity and mortality from intensive control, especially in older adults, and in those with long duration of diabetes disease and chronic complications. Although evidence in younger patients suggest that blood glucose levels should not be above 180 mg/dl (10.0 mmol/l), there are many unanswered questions and controversies regarding the benefits and risks, methods to achieve and maintain these levels while avoiding hypoglycemia (<70 mg% (3.9 mmol/l)) in the older population. Since the population is aging with a greater life expectancy, it is crucial that these questions be answered. Although several studies of inpatient non-ICU diabetes management have been published, few include older patients. This review will examine available recommendations and explore those controversies regarding non-ICU hospital management in this vulnerable patient population. Additional conditions that impact upon achieving glycemic control will also be discussed. Finally, the older individual has many special needs which may be more important to consider than in young or middle-aged individuals, when transitioning care from in-hospital to home in a patient-centered approach, as recommended by the American Diabetes Association (ADA) and European Society for the Study of Diabetes (EASD).
Literature
1.
go back to reference Association AMD. Diabetes management in the long-term care setting clinical practice guideline. In: Columbia, MD: AMDA; 2008; revised 2010. Association AMD. Diabetes management in the long-term care setting clinical practice guideline. In: Columbia, MD: AMDA; 2008; revised 2010.
2.
go back to reference Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta Georgia: U.S. Department of Health and Human Services; 2014. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta Georgia: U.S. Department of Health and Human Services; 2014.
3.
go back to reference National Diabetes Fact Sheet. General information and national estimates on diabetes in United States. In: U.S. Department of Health and Human Services CDC (ed.) Atlanta, GA; 2011. This data sheet has the current prevalence of diabetes in various age groups and shows the burden of the disease and its complications in the U.S. National Diabetes Fact Sheet. General information and national estimates on diabetes in United States. In: U.S. Department of Health and Human Services CDC (ed.) Atlanta, GA; 2011. This data sheet has the current prevalence of diabetes in various age groups and shows the burden of the disease and its complications in the U.S.
4.
go back to reference Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:29.CrossRef Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:29.CrossRef
5.
go back to reference Narayan KM, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29:2114–6.CrossRefPubMed Narayan KM, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29:2114–6.CrossRefPubMed
6.
go back to reference DIAMOND project group. Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med. 2006;23:857–66.CrossRef DIAMOND project group. Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med. 2006;23:857–66.CrossRef
7.
go back to reference Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. EURODIAB study group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373:2027–33.CrossRefPubMed Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. EURODIAB study group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373:2027–33.CrossRefPubMed
8.••
go back to reference Dhaliwal R, Weinstock RS. Management of type 1 diabetes in older adults. Diabetes Spectrum. 2014;27(1):9–20. doi:10.2337/diaspect.27.1.9. This article describes specific management issues important for elderly Type 1 diabetes care.CrossRef Dhaliwal R, Weinstock RS. Management of type 1 diabetes in older adults. Diabetes Spectrum. 2014;27(1):9–20. doi:10.​2337/​diaspect.​27.​1.​9. This article describes specific management issues important for elderly Type 1 diabetes care.CrossRef
9.
go back to reference Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet. 1997;50:1288–93.CrossRef Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet. 1997;50:1288–93.CrossRef
10.
go back to reference Schutt M, Fach EM, Seufert J, Kerner W, Lang W, Zeyfang A, et al. DPV Initiative and the German BMBF competence network diabetes network: multiple complications and frequent severe hypoglycaemia in ‘elderly’ and ‘old’ patients with type 1 diabetes. Diabet Med. 2012;29:e176–9.CrossRefPubMed Schutt M, Fach EM, Seufert J, Kerner W, Lang W, Zeyfang A, et al. DPV Initiative and the German BMBF competence network diabetes network: multiple complications and frequent severe hypoglycaemia in ‘elderly’ and ‘old’ patients with type 1 diabetes. Diabet Med. 2012;29:e176–9.CrossRefPubMed
11.
go back to reference Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008;31:539–43.CrossRefPubMed Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008;31:539–43.CrossRefPubMed
12.
go back to reference Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab. 2003;284:E7–E12.CrossRefPubMed Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab. 2003;284:E7–E12.CrossRefPubMed
13.
go back to reference Brown AF, Mangione CM, Saliba D, et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(Suppl Guidelines):S265–80.PubMed Brown AF, Mangione CM, Saliba D, et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(Suppl Guidelines):S265–80.PubMed
14.
go back to reference Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the US. Diabetes Care. 2006;29:2415–9.CrossRefPubMed Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the US. Diabetes Care. 2006;29:2415–9.CrossRefPubMed
15.
go back to reference Li Y, Burrows NR, Gregg EW, et al. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988–2008. Diabetes Care. 2012;35:273–7. Li Y, Burrows NR, Gregg EW, et al. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988–2008. Diabetes Care. 2012;35:273–7.
16.
go back to reference Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2013;98:3411–9.CrossRefPubMed Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2013;98:3411–9.CrossRefPubMed
19.
20.
go back to reference Reers C, Erbel S, Esposito I, et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol. 2009;160:185–91.CrossRefPubMed Reers C, Erbel S, Esposito I, et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol. 2009;160:185–91.CrossRefPubMed
21.
go back to reference Maedler K, Schumann DM, Schulthess F, et al. Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. Diabetes. 2006;55:2455–62.CrossRefPubMed Maedler K, Schumann DM, Schulthess F, et al. Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. Diabetes. 2006;55:2455–62.CrossRefPubMed
23.
go back to reference Meneilly GS. The pathophysiology of diabetes in the elderly. In: Medha N, Munshi LAL, editors. Geriatric diabetes. New York: Informa Healthcare; 2007. p. 29–36.CrossRef Meneilly GS. The pathophysiology of diabetes in the elderly. In: Medha N, Munshi LAL, editors. Geriatric diabetes. New York: Informa Healthcare; 2007. p. 29–36.CrossRef
25.
go back to reference Zeyda M, Stulnig TM. Obesity, inflammation, and insulin resistance—a mini-review. Gerontology. 2009;55:379–86.CrossRefPubMed Zeyda M, Stulnig TM. Obesity, inflammation, and insulin resistance—a mini-review. Gerontology. 2009;55:379–86.CrossRefPubMed
26.
27.
go back to reference Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–72.CrossRefPubMed Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–72.CrossRefPubMed
28.
go back to reference Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079–86.CrossRefPubMed Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079–86.CrossRefPubMed
30.
go back to reference Blaum C. Diabetes mellitus. In: Durso S, Sullivan GM, editors. Geriatric review syllabus: a core curriculum in geriatric medicine. 8th ed. New York: American Geriatric Society; 2013. p. 566–75. Blaum C. Diabetes mellitus. In: Durso S, Sullivan GM, editors. Geriatric review syllabus: a core curriculum in geriatric medicine. 8th ed. New York: American Geriatric Society; 2013. p. 566–75.
31.••
go back to reference Gates BJ, Walker KM. Physiological changes in older adults and their effect on diabetes treatment. Diabetes Spectrum. 2014;27:20–9. doi:10.2337/diaspect.27.1.20. This article describes the important issues specific to managing geriatric diabetic patients.CrossRef Gates BJ, Walker KM. Physiological changes in older adults and their effect on diabetes treatment. Diabetes Spectrum. 2014;27:20–9. doi:10.​2337/​diaspect.​27.​1.​20. This article describes the important issues specific to managing geriatric diabetic patients.CrossRef
32.•
go back to reference Schafer R, Letassy N, Randal D, Dorey C, Haas L, Barrier P. AADE position statement. Special considerations in the management and education of older persons with diabetes. 2009: 1–6. This article considers important diabetic care requirements for older persons with diabetes. Schafer R, Letassy N, Randal D, Dorey C, Haas L, Barrier P. AADE position statement. Special considerations in the management and education of older persons with diabetes. 2009: 1–6. This article considers important diabetic care requirements for older persons with diabetes.
33.
go back to reference Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRefPubMed Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRefPubMed
34.
go back to reference Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–21.CrossRefPubMed Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–21.CrossRefPubMed
35.
go back to reference Brunkhorst FM, Engel C, Bloos F, German Competence Network Sepsis (SepNet), et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New Engl J Med. 2008 Jan 10;358(2):125–39. Brunkhorst FM, Engel C, Bloos F, German Competence Network Sepsis (SepNet), et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New Engl J Med. 2008 Jan 10;358(2):125–39.
36.
go back to reference Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821–7.CrossRefPubMedCentralPubMed Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821–7.CrossRefPubMedCentralPubMed
37.
go back to reference Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–48.CrossRefPubMed Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–48.CrossRefPubMed
38.
go back to reference Knowler WC, Fowler SE, Hamman RF, et al. Diabetes prevention program research group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374:1677–86.CrossRefPubMed Knowler WC, Fowler SE, Hamman RF, et al. Diabetes prevention program research group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374:1677–86.CrossRefPubMed
39.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
40.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.CrossRef
41.
go back to reference Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577.CrossRefPubMed Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577.CrossRefPubMed
42.
go back to reference Gerstein HC, Miller ME, Byington RP, et al. Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.CrossRefPubMed Gerstein HC, Miller ME, Byington RP, et al. Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.CrossRefPubMed
43.
go back to reference Miller ME, Bonds DE, Gerstein HC, ACCORD Investigators, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. 2010;340:b5444.CrossRefPubMedCentralPubMed Miller ME, Bonds DE, Gerstein HC, ACCORD Investigators, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. 2010;340:b5444.CrossRefPubMedCentralPubMed
44.••
go back to reference Skyler JS, Bergenstal R, Bonow RO, American Diabetes Association; American College of Cardiology Foundation; American Heart Association, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American diabetes association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32:187–92. This position statement provides an analysis of recent studies regarding the question tight glucose control.CrossRefPubMedCentralPubMed Skyler JS, Bergenstal R, Bonow RO, American Diabetes Association; American College of Cardiology Foundation; American Heart Association, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American diabetes association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32:187–92. This position statement provides an analysis of recent studies regarding the question tight glucose control.CrossRefPubMedCentralPubMed
45.
go back to reference Patel A, MacMahon S, Chalmers J, ADVANCE Collaborative Group, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.CrossRefPubMed Patel A, MacMahon S, Chalmers J, ADVANCE Collaborative Group, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.CrossRefPubMed
46.
go back to reference Duckworth W, Abraira C, Moritz T, VADT Investigators, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.CrossRefPubMed Duckworth W, Abraira C, Moritz T, VADT Investigators, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.CrossRefPubMed
47.
go back to reference Duckworth WC, Abraira C, Moritz TE, Investigators of the VADT, et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA diabetes Trial. J Diabetes Complications. 2011;25:355–61.CrossRefPubMed Duckworth WC, Abraira C, Moritz TE, Investigators of the VADT, et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA diabetes Trial. J Diabetes Complications. 2011;25:355–61.CrossRefPubMed
48.
go back to reference Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–9.CrossRefPubMed Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–9.CrossRefPubMed
49.
go back to reference Huang ES, Liu JY, Moffet HH, et al. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34:1329–36.CrossRefPubMedCentralPubMed Huang ES, Liu JY, Moffet HH, et al. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34:1329–36.CrossRefPubMedCentralPubMed
50.
go back to reference Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and intensive care unit mortality: a retrospective cohort study. Crit Care. 2013;17:R52.CrossRefPubMedCentralPubMed Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and intensive care unit mortality: a retrospective cohort study. Crit Care. 2013;17:R52.CrossRefPubMedCentralPubMed
51.
go back to reference Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251–76.CrossRefPubMed Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251–76.CrossRefPubMed
55.
go back to reference Fisher BM, Hepburn DA, Smith JG, Frier BM. Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade. Horm Metab Res Suppl. 1992;26:109–10.PubMed Fisher BM, Hepburn DA, Smith JG, Frier BM. Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade. Horm Metab Res Suppl. 1992;26:109–10.PubMed
56.
go back to reference Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia. 1994;37:797–807.CrossRefPubMed Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia. 1994;37:797–807.CrossRefPubMed
57.
go back to reference Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52:1469–74.CrossRefPubMed Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52:1469–74.CrossRefPubMed
60.
go back to reference Koivikko ML, Karsikas M, Salmela PI, Tapanainen JS, Ruokonen A, Seppanen T, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia. 2008;51:426–35. doi:10.1007/s00125-007-0902-y.CrossRefPubMed Koivikko ML, Karsikas M, Salmela PI, Tapanainen JS, Ruokonen A, Seppanen T, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia. 2008;51:426–35. doi:10.​1007/​s00125-007-0902-y.CrossRefPubMed
61.
go back to reference Bremer JP, Jauch-Chara K, Hallschmid M, et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513–7.CrossRefPubMedCentralPubMed Bremer JP, Jauch-Chara K, Hallschmid M, et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513–7.CrossRefPubMedCentralPubMed
62.
go back to reference Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135–41.CrossRefPubMed Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135–41.CrossRefPubMed
64.••
go back to reference Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60:2342–56. doi:10.1111/jgs.12035. This position paper evaluates evidence and recommendations for treatment decisions of older adults with diabetes.CrossRef Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60:2342–56. doi:10.​1111/​jgs.​12035. This position paper evaluates evidence and recommendations for treatment decisions of older adults with diabetes.CrossRef
65.
go back to reference Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6:302–9.CrossRefPubMedCentralPubMed Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6:302–9.CrossRefPubMedCentralPubMed
66.
67.••
go back to reference Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American association of clinical endocrinologists and American diabetes association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353–69. doi:10.4158/EP09102.RA. This paper provides recommendations for inpatient glycemic control.CrossRefPubMed Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American association of clinical endocrinologists and American diabetes association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353–69. doi:10.​4158/​EP09102.​RA. This paper provides recommendations for inpatient glycemic control.CrossRefPubMed
68.
go back to reference Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American diabetes association workgroup on hypoglycemia. Diabetes Care. 2005;28:1245–9. This is a useful guideline to what is defined as hypoglycemia and why and how it can be reported.CrossRef Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American diabetes association workgroup on hypoglycemia. Diabetes Care. 2005;28:1245–9. This is a useful guideline to what is defined as hypoglycemia and why and how it can be reported.CrossRef
69.
go back to reference Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301:1556–64. doi:10.1001/jama.2009.496.CrossRefPubMed Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301:1556–64. doi:10.​1001/​jama.​2009.​496.CrossRefPubMed
71.
go back to reference Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012;6:1022–9.CrossRefPubMedCentralPubMed Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012;6:1022–9.CrossRefPubMedCentralPubMed
72.
go back to reference Maynard G, Wesorick DH, O’Malley C, Inzucchi SE. Society of hospital medicine glycemic control task force. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. J Hosp Med. 2008;3:29–41. doi:10.1002/jhm.354.CrossRefPubMed Maynard G, Wesorick DH, O’Malley C, Inzucchi SE. Society of hospital medicine glycemic control task force. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. J Hosp Med. 2008;3:29–41. doi:10.​1002/​jhm.​354.CrossRefPubMed
73.
go back to reference Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–94. doi:10.2337/dc09-2082. Useful review of the CVD risk that might be associated with severe hypoglycemia and the mechanisms involved.CrossRefPubMedCentralPubMed Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–94. doi:10.​2337/​dc09-2082. Useful review of the CVD risk that might be associated with severe hypoglycemia and the mechanisms involved.CrossRefPubMedCentralPubMed
74.••
go back to reference Draznin B, Gilden J, Golden SH, Inzucchi SE, for the PRIDE Investigators. Pathways to quality inpatient management: a call to action. Diabetes Care. 2013;36:1807–14. doi:10.2337/dc12-2508. This paper highlights the controversies and unanswered questions regarding inpatient management of diabetes and calls for studies designed to answer these challenges and gaps.CrossRefPubMedCentralPubMed Draznin B, Gilden J, Golden SH, Inzucchi SE, for the PRIDE Investigators. Pathways to quality inpatient management: a call to action. Diabetes Care. 2013;36:1807–14. doi:10.​2337/​dc12-2508. This paper highlights the controversies and unanswered questions regarding inpatient management of diabetes and calls for studies designed to answer these challenges and gaps.CrossRefPubMedCentralPubMed
75.
go back to reference Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.CrossRefPubMed Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.CrossRefPubMed
76.
go back to reference Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37:3001–9.CrossRefPubMedCentralPubMed Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37:3001–9.CrossRefPubMedCentralPubMed
77.
go back to reference Kosiborod M. Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction. Diab Vasc Dis Res. 2008;5:269–75.CrossRefPubMed Kosiborod M. Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction. Diab Vasc Dis Res. 2008;5:269–75.CrossRefPubMed
78.
go back to reference American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care. 2014;37 Suppl 1:S14–80.CrossRef American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care. 2014;37 Suppl 1:S14–80.CrossRef
79.
go back to reference Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin: myth or insanity? Am J Med. 2007;120:563–7.CrossRefPubMed Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin: myth or insanity? Am J Med. 2007;120:563–7.CrossRefPubMed
80.
go back to reference Baldwin D, Kinnare K, Draznin B, et al. Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN). Diabetes. 2012;61 Suppl 1:A1070. Baldwin D, Kinnare K, Draznin B, et al. Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN). Diabetes. 2012;61 Suppl 1:A1070.
82.
go back to reference Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, et al. Insulin inhibits intranuclear factor kappa ß and stimulates Ikappaß in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect. J Clin Endocrinol Metab. 2001;86:3257–65.PubMed Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, et al. Insulin inhibits intranuclear factor kappa ß and stimulates Ikappaß in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect. J Clin Endocrinol Metab. 2001;86:3257–65.PubMed
83.••
go back to reference Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16–38. These guidelines provide clinical practice recommendations for management of patients with diabetes mellitus.CrossRefPubMed Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16–38. These guidelines provide clinical practice recommendations for management of patients with diabetes mellitus.CrossRefPubMed
84.
go back to reference Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61.CrossRefPubMedCentralPubMed Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61.CrossRefPubMedCentralPubMed
85.
go back to reference Chaudhuri A, Dandona P, Fonseca V. Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab. 2012;97:3079–91.CrossRefPubMed Chaudhuri A, Dandona P, Fonseca V. Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab. 2012;97:3079–91.CrossRefPubMed
86.
go back to reference Ng KW, Allen ML, Desai A, Macrae D, Pathan N. Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients. Circulation. 2012;125:721–8.CrossRefPubMed Ng KW, Allen ML, Desai A, Macrae D, Pathan N. Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients. Circulation. 2012;125:721–8.CrossRefPubMed
87.
go back to reference Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes. Basal Plus Trial Diabetes Care. 2013;32:2169–74.CrossRef Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes. Basal Plus Trial Diabetes Care. 2013;32:2169–74.CrossRef
88.
go back to reference Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:564–9.CrossRefPubMedCentralPubMed Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:564–9.CrossRefPubMedCentralPubMed
90.
go back to reference Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4:3–15. doi:10.1002/jhm.391.CrossRefPubMed Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4:3–15. doi:10.​1002/​jhm.​391.CrossRefPubMed
91.
92.
go back to reference Oyer DS, Shah A, Bettenhausen S. How to manage steroid diabetes in the patient with cancer. J Support Oncol. 2006;4:479–83.PubMed Oyer DS, Shah A, Bettenhausen S. How to manage steroid diabetes in the patient with cancer. J Support Oncol. 2006;4:479–83.PubMed
93.
go back to reference Umpierrez GE, Schwartz S. Use of Incretin-based therapy in hospitalized patients with hyperglycemia. Endocrine Practice 2014: (rapid electronic article in press) DOI 10.4158/EPI 13471.RA. Umpierrez GE, Schwartz S. Use of Incretin-based therapy in hospitalized patients with hyperglycemia. Endocrine Practice 2014: (rapid electronic article in press) DOI 10.​4158/​EPI 13471.RA.
94.
go back to reference Hirschman KB, Bixby B. Transitions in care from the hospital to home for patients with diabetes. Diabetes Spectrum. 2014;27:192–5.CrossRef Hirschman KB, Bixby B. Transitions in care from the hospital to home for patients with diabetes. Diabetes Spectrum. 2014;27:192–5.CrossRef
95.••
go back to reference Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79. These guidelines recommend that diabetes management should be individualized as a patient-centered approach.CrossRefPubMedCentralPubMed Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79. These guidelines recommend that diabetes management should be individualized as a patient-centered approach.CrossRefPubMedCentralPubMed
96.
go back to reference Healy SJ, Dawn B, Cara H, Andrew L, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013;36(10):2960–7. dc13-0108v1 36/10/2960.CrossRefPubMedCentralPubMed Healy SJ, Dawn B, Cara H, Andrew L, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013;36(10):2960–7. dc13-0108v1 36/10/2960.CrossRefPubMedCentralPubMed
97.
go back to reference American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21:296–309.CrossRef American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21:296–309.CrossRef
Metadata
Title
Non-ICU Hospital Care of Diabetes Mellitus in the Elderly Population
Authors
Janice L. Gilden
Aditi Gupta
Publication date
01-05-2015
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 5/2015
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-015-0596-3

Other articles of this Issue 5/2015

Current Diabetes Reports 5/2015 Go to the issue

Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)

Management of Glycemia in Diabetic Patients with Stage IV and V Chronic Kidney Disease

Diabetes, Other Diseases, and New Complications: Emerging Associations (JJ Nolan, Section Editor)

Cardiac Autoimmunity as a Novel Biomarker, Mediator, and Therapeutic Target of Heart Disease in Type 1 Diabetes

Other Forms of Diabetes (R Bonadonna, Section Editor)

The Diagnosis of Posttransplantation Diabetes Mellitus: Meeting the Challenges

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

Clinical Trials in Youth-Onset Type 2 Diabetes: Needs, Barriers, and Options

Hospital Management of Diabetes (GE Umpierrez, Section Editor)

Transitioning Safely from Intravenous to Subcutaneous Insulin

Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)

Is Fenofibrate a Reasonable Treatment for Diabetic Microvascular Disease?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.